AMBIT BIOSCIENCES CORP

Profile

Company Names

AMBIT BIOSCIENCES CORP

Addresses

4215 SORRENTO VALLEY BLVD., SAN DIEGO, CA 92121

Phone Numbers

8583342100

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$84,700,742.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2012-10-25 
$22,206,064.00 
$44,814,271.00 
$22,608,207.00 
Equity 
6
2012-05-18 
$7,066,803.00 
$11,482,825.00 
$4,416,022.00 
 
5
2011-05-18 
$22,000,006.00 
$30,026,638.00 
$8,026,632.00 
Equity 
4
2010-09-30 
$14,999,327.00 
$15,913,126.00 
$913,799.00 
Debt 
3
2010-03-31 
$12,000,000.00 
$13,440,000.00 
$1,440,000.00 
Debt 
2
2009-07-08 
$0.00 
$2,360,980.00 
$2,360,980.00 
 
1
2009-06-05 
$6,428,542.00 
$19,717,220.00 
$13,288,678.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
P. 
BONITA 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  CLEMENTIA PHARMACEUTICALS INC.   |  ORBIMED NEW HORIZONS FUND, L.P.   |  ORBIMED GENESIS FUND, L.P.   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP   |  ORBIMED RCO IV OFFSHORE FEEDER, LP   |  ORBIMED PRIVATE INVESTMENTS IX, LP   |  ORBIMED RCO V OFFSHORE FEEDER, LP   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
ATHENA 
 
COUNTOURIOTIS 
EXECUTIVE OFFICER
AMBIT BIOSCIENCES CORP   |  TROVAGENE, INC.   |  AVENZO THERAPEUTICS, INC.   |  CAPSTAN THERAPEUTICS, INC.
STEVEN 
 
ELMS 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  CENERX BIOPHARMA INC   |  PERNIX THERAPEUTICS HOLDINGS, INC.   |  LOXO ONCOLOGY, INC.   |  14NER ONCOLOGY, INC.   |  ELEVATION ONCOLOGY, INC.   |  TREELINE BIOSCIENCES, INC.   |  MARKER THERAPEUTICS, INC.
STANDISH 
M. 
FLEMING 
DIRECTOR
AMBIT BIOSCIENCES CORP
ALAN 
 
FUHRMAN 
EXECUTIVE OFFICER
NAVISCAN PET SYSTEMS INC   |  NAVISCAN, INC   |  HEALIONICS CORP   |  AMBIT BIOSCIENCES CORP   |  CHECKMATE PHARMACEUTICALS, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  TYRA BIOSCIENCES, INC.
FAHEEM 
 
HASNAIN 
DIRECTOR
SENTE INC   |  AMBIT BIOSCIENCES CORP   |  RECEPTOS, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  TOCAGEN INC   |  WINDSOR BOYS RACING, LLC   |  GOSSAMER BIO, INC.   |  KURA ONCOLOGY, INC.
KERRY 
A. 
KELLY, J.D. 
EXECUTIVE OFFICER
AMBIT BIOSCIENCES CORP
ALAN 
J. 
LEWIS, PH.D. 
DIRECTOR, EXECUTIVE OFFICER
AMBIT BIOSCIENCES CORP
ALLAN 
 
MARCHINGTON 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  AMBRX INC   |  SOTERA WIRELESS, INC.   |  RUIYI, INC.   |  BIRD ROCK BIO, INC.   |  MEDIAR THERAPEUTICS, INC.
MICHAEL 
A. 
MARTINO 
EXECUTIVE OFFICER, DIRECTOR
ONCOGENEX PHARMACEUTICALS, INC.   |  AMBIT BIOSCIENCES CORP
CHRISTOPHER 
J. 
MORL 
EXECUTIVE OFFICER
AMBIT BIOSCIENCES CORP   |  DECIPHERA PHARMACEUTICALS, LLC
ISAI 
 
PEIMER 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  SYNOVEX CORP   |  ADHERON THERAPEUTICS, INC.
JOSEPH 
 
REGAN 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  TARGETED GROWTH INC
M. SCOTT 
 
SALKA 
EXECUTIVE OFFICER, DIRECTOR
AMBIT BIOSCIENCES CORP
WENDELL 
 
WIERENGA, PH.D. 
EXECUTIVE OFFICER
AMBIT BIOSCIENCES CORP
SAIID 
 
ZARRABIAN 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  CYNTELLECT, INC   |  INTREXON CORP   |  LA JOLLA PHARMACEUTICAL CO   |  KINTARA THERAPEUTICS, INC.
ALEXANDER 
 
ZUKIWSKI 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  ONCOLYZE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-11-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-25 
2012-05-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2012-05-18 
2011-07-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-05-18 
2010-10-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-30 
2010-04-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-31 
2009-07-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-07-08 
2009-06-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#